Page 80 - Express Scripts News Today

NCPA is skeptical that Express Scripts, owned by Cigna, will walk the walk on its recent announcement that it plans to evolve the one-sided business relationship PBMs exploit that results in decreased transparency, higher patient prescription drug costs, and stifled competition. Based on past actions by Cigna-Express Scripts, NCPA believes there is no basis for independent pharmacies to have confidence they will actually see increased reimbursements from Cigna-Express Scripts.

Sen. Bernie Sanders announced Friday that CEOs from the major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi will testify at a hearing next month.

Pictured here is a Novo Nordisk insulin pen on display on March 14, 2023 in Miami, Florida.

Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.

Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.

Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.

Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.

Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.

Sen. Bernie Sanders announced Friday that CEOs from the major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi will testify at a hearing next month. The three companies, which collectively... | June 18, 2023

CHARLESTON — Low prescription reimbursement rates that result in net losses have the state’s independent pharmacists questioning whether they can continue to accept coverage plans through the Public Employee Insurance